Taiwan Liposome Aktie - TLC

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

7,00

Gebot

6,66

Fragen

7,10

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

7,00

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Highlights of Dr. David Hunter’s Oral Presentation at ACR’s Late Breaking Abstracts Session

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Professor David Hunter...

TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACR

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 08, 2023 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a...

TLC Announces TLC599 Agreement with Endo

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 13, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a...

TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & Therapy

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, March 07, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences, a...

TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares

This communication does not constitute an offer of any securities for sale or subscription or a solicitation...

TLC Reports Second Quarter 2021 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Aug. 12, 2021 (GLOBE NEWSWIRE) -- TLC, a clinical-stage...

TLC Announces Details of Stock Swap Transactions

TAIPEI, Taiwan, July 05, 2021 (GLOBE NEWSWIRE) -- Taiwan Liposome Company (Nasdaq: TLC, TWO: 4152, “the...

TLC and Zydus Enter Agreement to Launch AmphoTLC™ in India

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 26, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO:...

TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in India

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 25, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO:...

InspirMed Highlights Encouraging Data on ISPM21 and ISPM19 – Inhalable Liposome Formulations of Antiviral Drugs for COVID-1...

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 23, 2021 (GLOBE NEWSWIRE) -- InspirMed Inc., a subsidiary...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

TLC - Frequently Asked Questions (FAQ)

What is the current Taiwan Liposome share price?

The current share price of Taiwan Liposome is US$ 7,00

What is the 1 year trading range for Taiwan Liposome share price?

Taiwan Liposome has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
CAPSCapstone Holding Corp	US$ 3,50 (1.300,00%)	1,59k
SUNESUNation Energy Inc	US$ 0,4152 (134,44%)	291,31M
BTOGBit Origin Ltd	US$ 0,48175 (72,05%)	120,15M
GVVisionary Holdings Inc	US$ 7,12 (45,60%)	30,86M
WHLRWheeler Real Estate Investment Trust Inc	US$ 1,4397 (37,11%)	12,78M
SHOTWSafety Shot Inc	US$ 0,14 (-39,13%)	770
ACXPAcurx Pharmaceuticals Inc	US$ 0,4724 (-27,55%)	410,74k
AGMHAGM Group Holdings Inc	US$ 0,162 (-24,65%)	18,19M
LUNRIntuitive Machines Inc	US$ 8,73 (-22,47%)	21,76M
YXTYXT.COM Group Holding Ltd	US$ 1,05 (-21,05%)	101,07k
SUNESUNation Energy Inc	US$ 0,4152 (134,44%)	291,31M
BTOGBit Origin Ltd	US$ 0,48175 (72,05%)	120,15M
PSTVPlus Therapeutics Inc	US$ 1,6702 (15,99%)	65,58M
ICONIcon Energy Corporation	US$ 0,177 (22,07%)	60,81M
FAMIFarmmi Inc	US$ 0,252198 (10,32%)	55,59M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Taiwan Liposome Company Ltd (TLC)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

TLC Neueste Nachrichten

Highlights of Dr. David Hunter’s Oral Presentation at ACR’s Late Breaking Abstracts Session

TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACR

TLC Announces TLC599 Agreement with Endo

TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & Therapy

TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares

TLC Reports Second Quarter 2021 Financial Results and Provides Business Update

TLC Announces Details of Stock Swap Transactions

TLC and Zydus Enter Agreement to Launch AmphoTLC™ in India

TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in India

InspirMed Highlights Encouraging Data on ISPM21 and ISPM19 – Inhalable Liposome Formulations of Antiviral Drugs for COVID-1...

TLC - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Taiwan Liposome Company Ltd (TLC) Börsenkurse

Taiwan Liposome Company Ltd (TLC)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

TLC Neueste Nachrichten

Highlights of Dr. David Hunter’s Oral Presentation at ACR’s Late Breaking Abstracts Session

TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACR

TLC Announces TLC599 Agreement with Endo

TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & Therapy

TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares

TLC Reports Second Quarter 2021 Financial Results and Provides Business Update

TLC Announces Details of Stock Swap Transactions

TLC and Zydus Enter Agreement to Launch AmphoTLC™ in India

TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in India

InspirMed Highlights Encouraging Data on ISPM21 and ISPM19 – Inhalable Liposome Formulations of Antiviral Drugs for COVID-1...

TLC - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR